Quarterly Result14 May 2025, 10:54 pm
Lupin Ltd Reports Strong FY2025 Results with 712.9% YoY Growth in Sales and 470.8% YoY Growth in PAT
AI Summary
Pharma major Lupin Limited reported its financial performance for the quarter and fiscal year ending March 31, 2025. The audited results showed a significant increase in sales and profitability, driven by in-line and new products, and operational efficiencies. The company has recommended a dividend of 600%.
Key Highlights
- Sales increased by 712.9% YoY to INR 221,921 Mn in FY2025
- Profit After Tax (PAT) grew by 470.8% YoY to INR 33,063 Mn in FY2025
- Gross Profit was INR 38,760 Mn in Q4 FY2025 with a gross margin of 69.7%
- Personnel cost was 18.0% of sales at INR 10,013 Mn in Q4 FY2025
- Net Debt stands at INR -3,096 Mn as on March 31, 2025